Agenus, Inc. (AGEN)
3.24
+0.02
(+0.62%)
USD |
NASDAQ |
Feb 25, 16:00
3.24
0.00 (0.00%)
After-Hours: 17:25
Agenus Research and Development Expense (Quarterly) : 23.60M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cardiff Oncology, Inc. | 8.197M |
| Curis, Inc. | 6.432M |
| LadRx Corp. | 0.0288M |
| Plus Therapeutics, Inc. | 2.436M |
| Windtree Therapeutics, Inc. | 1.537M |